Market Research Blog

Point-Of-Care Genetic Testing Market Overview

Point-of-Care testing is defined as the clinical testing performed at or near the site where clinical care is being given to the patient. It can be performed by patients itself or any personnel. Consecutively, analyzing the DNA and finding out the best treatment option based on the genetic makeup of the patient constitute Point-of-Care genetic testing. This is a fast and quick technique based on personal genomics so to allow the efficient functioning of the drug.

The idea behind this point-of-care genetic testing approach is to reduce the diagnosis time, inconvenience faced by patients and to follow personalized medicine approach for specific patient. Generally, all the diseases are combination of various genetic factors, and current genetic testing techniques require a lot of time in analyzing the problem. As a result, the use of Point-of Care genetic testing systems is prevalent in quickly diagnosing and guiding the doctors to head in a right direction.

Any Queries, Contact Us @ https://www.futuremarketinsights.com/askus/rep-gb-3138

Point-of-Care Genetic testing involves amplification of genetic material and then real-time analysis to detect the genetic variations among people. The first point-of-care version of a real-time nucleic acid detection system is the Cepheid’s Xpert system, going to be launched this year. It combines fully integrated sample preparation for amplification and detection process. This system is designed to purify, concentrate, detect, and recognize targeted nucleic acid sequences delivering diagnosis using unprocessed samples approximately within 30 minutes.

Point-of-Care Genetic Testing Market: Drivers & Restraints

The point-of-care genetic testing technology possesses convenient and immediate action for a therapeutic condition. The growth is likely to continue with the aim of providing less costly and closer to patients care. The use of genetics has become prominent nowadays in almost every pediatric condition, and this technology overcomes the limitations and challenges of current molecular testing techniques.

Pressure on healthcare budgets and the trend to patient-centered care might be perceived as problems confined to the developed world. Moreover, the increase in population and westernization in the developing countries like China and India links it with the increase in the healthcare problems. Due to poverty and lack of sources, Point-of-Care genetic testing technology has a major scope in these countries by providing diagnostics available at low prices and at patient’s bedside.

There are some technological limitations like failure to detect abnormal results, standardization, technological expertise, algorithmic & software complications, higher cost of maintenance & repair, poor tests result in case of contaminated samples, and sample specificity in the use of point-of-care genetic testing systems. In addition, the high cost of Point-of-Care genetic test and limited reimbursement support is hindering the growth of point-of-care genetic testing market.

Request For Table Of Content @ https://www.futuremarketinsights.com/toc/rep-gb-3138

Point-of-Care Genetic Testing Market: Overview

A global trends of making healthcare service more patient-centeric than the service provider shows an expanding growing opportunities for point-of-care genetic testing, as there are lots of funding available from multiple sources including NIH, US Department of Defence as well as various private foundations and biopharmaceutical companies. The point-of-care genetic testing market includes various types of testing includes diabetes, hematology, oncology, infectious disease, and others indications.

Point-of-Care genetic testing is going beyond the laboratory, as FDA granted its first CLIA waiver to a nucleic acid based test. The Alere I Influenza A&B and cobas Liat System and Strep A from Roche have received a CLIA waiver in 2015. In the cardiovascular domain, Spartan Biosciences received the approval from Health Care Canada for their Spartan RX CYP2C19 system in 2014, a genetic test that can be used to govern whether patients receiving the antiplatelet medication clopidigrel (Plavix) following percutaneous coronary intervention (PCI) have CYP2C19 mutations that may weaken their ability to metabolize the drug.

Point-of-Care Genetic Testing Market: Region-wise Outlook

Based on geography, the point-of-care genetic testing market is segmented into North America, Latin America, Western Europe, Eastern Europe, APEJ, Japan and Middle & Africa. Sustained implementation of point-of-care genetic testing requires that new technologies address the need of targeted settings. The combined power of microfluidics and smartphone technologies will be going to boost the market of point-of-care molecular testing. The US is recognized at the top country in the sector of Point-of-Care genetic testing market because of technological advancement, awareness among the population and high per capita income. In Europe, Germany is also recognized as the market player in this industry. Asia-Pacific is expected witness significant growth rate in the coming years due to increasing investment in cancer research, increasing awareness and funding by government to curb the prevalence of infectious diseases and active participation of corporates in the healthcare technologies.

Point-of-Care Genetic Testing Market: Key Players

Cepheid, IQuum, Biocartis, Abbott, Idaho Technologies, ThermoFisher, Roche, Optigene, Lumora are some of the global key players in point-of-care genetic testing. In 2016, Biocartis Idylla’s distribution rights were also granted to Thermofisher in the US. The Idylla platform is a fully integrated system enabling laboratories to perform a broad range of applications in oncology and beyond. But in 2014, Iquum’s Liat Analyzers’ rights were acquired by Roche Molecular Diagnostics.

The report covers exhaustive analysis on:

• Market Segments
• Market Dynamics
• Market Size
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Value Chain

The regional analysis includes:

• North America (U.S., Canada)
• Latin America (Mexico. Brazil)
• Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
• Eastern Europe (Poland, Russia)
• Asia-Pacific(China, India, ASEAN, Australia & New Zealand)
• Japan
• The Middle Eastand Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Point-of-Care Genetic Testing Market: Segmentation

Preclinical MRI Equipment Market Overview

Currently, non-invasive and in-vivo imaging modalities have become quite popular in the study of animal models longitudinally. Preclinical imaging is a non-invasive technique used to visualize living animals in order to study various diseases quantitatively, in real time, with the ability to monitor the disease progression rate at molecular level.

Suitable models for preclinical in-vivo studies include, positron emission tomography scanners (PET), single photon emission tomography scanners (SPECT), ultrasound, magnetic resonance imaging (MRI), compute tomography etc. Preclinical MRI imaging technique employs use of large magnets that help generating magnetic fields, carefully targeted electromagnetic pulses, and computer software in order to obtain organ level anatomical images with high spatial resolution. These generated magnetic fields results in formation of paramagnetic atoms including hydrogen, gadolinium, and manganese created by the radiofrequency (RF) coils inside the MRI machine.

For Information On The Research Approach Used In The Report, Ask Analyst @ https://www.futuremarketinsights.com/askus/rep-gb-2891

The machine then captures the relaxation of the atoms at the time when the RF pulse is ceased thus generating an image based on the resonance characteristic of the body part being studied. The preclinical MRI equipment’s are used in study of various life threatening disorders including cancer, cardiovascular disorders, neurological and infectious and inflammatory diseases etc. Apart from this the device can also be used in the transitional research and new drug development.

Preclinical MRI Equipment Market: Drivers and Restraints

Preclinical MRI equipment market is expected to be driven by increasing research and development activities in order to examine key pathophysiological episodes at each disease stage and in development of novel therapeutic drug in treatment of various disease indications. Furthermore, launch of new preclinical MRI equipment’s with advanced MRI technology and additional innovative features is further expected to drive the revenues of preclinical MRI equipment market.

For example, BioSpec 3T Preclinical MRI System by Brukur is a multi-purpose, preclinical MRI system that is used for studying mice and rats. The system delivers expanded range of RF coil for multipurpose applications is with superior cryogen free design. Preclinical MRI equipment offers reduced biological variability with expanded opportunity to deliver unique information in distinct forms. This will also result in substantial reduction in the number of animal models required in studying several diseases.

For Information On The Research Approach Used In The Report, Request TOC@ https://www.futuremarketinsights.com/toc/rep-gb-2891

Furthermore, integration preclinical MRI equipment machines with other imaging modalities such as PET, SPECT and CT has also resulted in significant revenue generation in global preclinical MRI equipment market. Such hybrid imaging modalities not only deliver functional information but also delivers efficient and unique tools to evaluate new chemical entities and candidate drugs.

Challenges including high cost of the device is restricting the use of preclinical MRI equipment into clinical practice, inadequate infrastructure provision and lack of skilled professionals in some of the emerging economies is expected to hamper the market growth of preclinical MRI equipment market over the forecast period.

Preclinical MRI Equipment Market: Overview

Preclinical MRI equipment’s are widely available for preclinical imaging and research purpose. The global market for preclinical MRI equipment is expected to generate higher revenues over the forecast period. This is attributed to extensive ongoing studies in order to diagnose and evaluate several diseases.

Also launch of many preclinical MRI equipment’s in the market with highest level of accuracy and sensitivity is expected to drive the revenues of preclinical MRI equipment’s over the forecast period. A recent trend in preclinical imaging is increasing use of multimodality MRI imaging technique with large diameter bore better suited for imaging of whole animal body.

Preclinical MRI Equipment Market: Regional Wise Outlook

Geographically, global preclinical MRI Equipment market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. The market in Asia Pacific and Japan is expected to grow at significant CAGR due to growing number of research institutes in countries such as India, Australia and Japan, thus leading to extensive research in the field of clinical biology.

North America will continue to hold largest share in the preclinical MRI equipment market as majority of the key market players located in the U.S. coupled with presence skilled professionals in the region which are culture positive to innovation. Europe is expected to take second largest share in the global preclinical MRI equipment market. This is attributed to new preclinical MRI machines launches in the region by several manufacturers.

Preclinical MRI Equipment Market: Key Players

Some of the major players in the global custom assay market are Bruker Corporation, Agilent Technologies, Simens Healthcare, Aspect Imaging, FUJIFILM Holdings Corporation, MR Solutions Ltd., Perkin Elmer, Inc., Mediso Medical Imaging Systems and others. Companies often provide custom assay services, where user can define their requirements and specifications and assay is built accordingly by the manufacturer.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

The report covers exhaustive analysis on:

• Market Segments
• Market Dynamics
• Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Technology
• Value Chain

Regional analysis includes

• North America (U.S., Canada)
• Latin America (Mexico, Brazil)
• Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
• Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
• Asia Pacific Excluding Japan (China, India, Australia & New Zealand)
• Japan
• Middle East and Africa (GCC, S. Africa, Rest Of MEA)

Preclinical MRI Equipment Market: Segmentation

Tentatively, the global preclinical MRI equipment market has been segmented on the basis of modality, end user, and geography.

Stent Graft Balloon Catheter Market Overview

Stent graft balloon catheter, is a soft catheter with an inflatable “balloon” used during a catheterization procedure to enlarge a narrow opening in the coronary artery. These catheters are generally used for expanding vascular prosthesis or during temporary occlusion of large vessels thus used in many endovascular treatment of abdominal and thoracic aortic diseases. Generally the balloon stents are used in bypass graft surgery and balloon angioplasty. These stents prevent the risk of abrupt artery closure and re-narrowing that occurred in many patients operated for angioplasty.

The stent graft balloon catheter market has evolved gradually from simple stents to modified balloon stent catheters. This market comprises of balloon catheters used for stent grafting during angioplasty.

Get a Sample Copy of Report – https://www.futuremarketinsights.com/reports/sample/rep-gb-1628

Stent Graft Balloon Catheter Market: Drivers & Restraints

The primary factor for the growth of global stent graft balloon catheter market is the increasing number of hospital admissions attributed to rising incidence of atherosclerosis patients, and rising prevalence of CAD (Coronary Artery Disease) worldwide. Secondly growing healthcare expenditure levels and the introduction of advanced technologiesin balloon catheter drives the market growth for stent graft balloon catheter over the forecast period. However high cost of angioplasty procedures are the factors restraining the market growth of stent graft balloon catheter market over the forecast period.

Stent Graft Balloon Catheter market is mainly dominated by trends such as introduction of drug eluting balloons. Also increasing inclination to opt for balloons with drug delivery, which can deliver the medication at the local site, are effective alternatives for administering the drug intravenously. However there are several types of balloon catheters available in the market, which helps in curing coronary artery diseases and many such trends expected to dominate the market over the forecast period.

Stent Graft Balloon Catheter Market: Overview

Depending on geographic region, the stent graft balloon catheter market is segmented into seven key regions: North America, Latin America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa.

Globally, stent graft balloon catheter market is expected to witness healthy growth in the near future due to increasing prevalence of coronary artery disease and the rise in per capita expenditure on healthcare in the developing nations. Stent graft balloon catheter market is anticipated to show highest share is of North America followed by Europe owing to technological advancement, sophisticated healthcare infrastructure and increasing awareness regarding angioplasty procedures available in the market.

Request Table of Content for this Insight – https://www.futuremarketinsights.com/toc/rep-gb-1628

Also it has been analyzed that balloon catheter stenting for coronary applications has been widely adopted in clinical practice and is associated with improved health outcomes in Europe. Asia-Pacific market is expected to register fastest growth owing to the rise in geriatric population and increasing obesity, which ultimately gives rise to the number of patients suffering for coronary artery diseases over the forecast period.

Stent Graft Balloon Catheter Market: Key Players

Some of the key market players in stent graft balloon catheter market includes Medtronic, Boston Scientific, Abbott Laboratories, Cordis, Atrium Medical, W. L. Gore & Associates Inc., JOTEC GmbH, QXMédical, LLC etc. these players are entering into mergers & acquisitions, strategic collaborations, and product portfolio expansions, distribution agreements which are their key sustainability strategies. Secondly many local players have started entering in this lucrative market.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

The report covers exhaustive analysis on:

• Market Segments
• Market Dynamics
• Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Technology
• Value Chain

Regional analysis includes

• North America (U.S., Canada)
• Latin America (Mexico. Brazil, Argentina)
• Western Europe (Germany, Italy, France, U.K, Spain, Rest of Western Europe)
• Eastern Europe (Russia, Poland)
• Asia Pacific (China, India, ASEAN, Australia & New Zealand)
• Japan
• Middle East and Africa (GCC, S. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Stent Graft Balloon Catheter Market: Segmentation

This market is segmented on the basis of product type and end user

Peripheral Embolization Device Market Overview

Embolization is a process through which embolus is placed into the blood vessel to block the blood flow to a particular area of the body. The embolus is usually a blood clot formed due to clotting of blood cells. However, the artificial embolus is used to close off blood vessels to prevent the blood from reaching a particular part of the body to eliminate abnormal conditions in the body like a renal aneurysm, arteriovenous fistula, hypogastric artery embolization, endoleak embolization, GI bleeding and treatment of tumors.

Peripheral embolization is usually used to shrink tumors by blocking the blood flow to it. Peripheral embolization devices often use embolus made up of various drugs which along with blocking the blood flow also are targeted towards the treatment of a tumor. Embolization is efficient and less invasive as compared to open surgery and therefore poses a little risk to the patient.

Ask an Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-1793

Peripheral Embolization Device Market: Drivers and Restraints

The global peripheral embolization device market is driven by the rising incidence of cancer and cardiovascular diseases. According to CDC (Centers for Disease Control and Prevention) by 2025, 19.3 million cases of cancer cases are expected to be diagnosed each year, which in turn is expected to increase demand for peripheral embolization devices for early treatment of malignant tumors. The increasing mortality rate due to cardiovascular diseases is expected to boost demand for peripheral embolization devices.

Increasing cardiovascular patients owing rising global geriatric population is expected to provide high growth opportunities for the peripheral embolization devices manufacturers over the forecast period.  Moreover, technological developments in new peripheral embolization devices aimed to increase safety among patients and ease of use for physicians is expected to provide significant growth opportunities for the peripheral embolization devices manufacturers. However, the high cost of peripheral embolization devices and complications like coil migration, perforations, and spasms among patients is expected to hamper market growth over the forecast period.

Peripheral Embolization Device Market: Region – wise Outlook

The peripheral embolization device market is expected to witness healthy growth throughout the forecast period with North America expected to be the leading market. High demand for peripheral embolization devices from cancer patients is expected to boost the market growth over the forecast period. Favorable reimbursement policies and up gradation in the compensation for the patients is North America is projected to drive demand for peripheral embolization devices in North America over the forecast period.

Ask for TOC @ https://www.futuremarketinsights.com/toc/rep-gb-1793

Moreover, several global manufacturers in this region are expected to promote the use of peripheral embolization devices and in turn is supposed to increase the adoption rate of the devices. Western Europe is expected to be second largest market followed by North America owing to high awareness related to the use of peripheral embolization devices for treatment of cardiovascular and bleeding disorders.

APEJ (Asia-Pacific excluding Japan) and Japan are expected to follow next after Western Europe owing to high population and increasing the incidence of cardiovascular diseases in these regions along with growing per capita healthcare expenditure in countries like India and China. Eastern Europe and the Middle East and Africa (MEA) is expected to increase significantly owing to the rise in cancer incidence rate and manufacturers focusing on expansion strategies in this regions.

Peripheral Embolization Device Market: Key Players

Some key players in peripheral embolization market are Boston Scientific Corporation, Medtronic, Inc., Cook Medical, St. Jude Medical, Inc., Penumbra, Inc., Metactive Medical, Inc., Terumo Corporation and others. The companies are focused on development of new peripheral embolization devices with increased safety and ease of use.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

The report covers exhaustive analysis on:

• Market Segments
• Market Dynamics
• Market Size
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Value Chain

Regional analysis includes

• North America (U.S., Canada)
• Latin America (Mexico. Brazil)
• Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
• Eastern Europe (Poland, Russia)
•  APEJ (China, India, ASEAN, Australia & New Zealand)
• Japan
• Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Peripheral Embolization Device Market: Segmentation

The global peripheral embolization device market are segmented into product type and end user

Kids Sports Injury Treatment Market Overview

The number of kids taking part in sports activities has been increasing rapidly over the last few years which is resulting in a significant rise in the sport injury incidences. Even though there are various advanatges of active participation in sports, such as physical fitness, building up of self-confidence and learning to work in a team, there is always a risk of sports-related injuries.

The associated risk of an injury increases by a lack of protective gear during sports activities like hockey, boxing, wrestling, skateboarding, Ice hockey, soccer, snow skiing or snowboarding, bicycling, baseball, softball, basketball. Kids sports injuries are injuries which may either develop as a result of inappropriate practice or training.

Head injury, elbow injury and soft-tissue injuries are the most common sport injuries in kids. According to the United State Centers for Disease Control and Prevention, more than 38 Mn adults and children in the U.S. participate in organized sports competitions every year and approximately 2.6 Mn will be treated for injuries related to sports.

Get Table Of Content of Report @ https://www.futuremarketinsights.com/toc/rep-gb-1214

Kids Sports Injury TreatmentMarket: Drivers and Restraints

The primary factor for the growth of global kids’ sports injury market is growing accidents during practice or during performance as the number of children participants in sport activities increases every year from all the age groups. Adequate sports training programs are conducted through private trainers and sport clubs to reduce the accident rate while training so that associated risks are minimized during performances or competitions.

Main factor that restrain the global kids sports injury treatment market is increasing awareness of the parents, providing modified training programs and using safety tools, equipment or safety apparels for the children while practicing.

Kids Sports Injury Treatment Market: Overview

According to the data from the United State Consumer Product Safety Commission’s National Electronic Injury Surveillance System of 100 hospital emergency departments, most of patients that are injured between the age of five and 16 years are injures while playing or practicing basketball, football, baseball, ice hockey, soccer or softball. A kid should get first-aid attention immediately for acute injuries. A visit to a pediatrician is essential even if the injury appears normal and proper diagnosis is necessary for quick healing.

Request For Report Sample Copy @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1214

Kids Sports Injury Treatment Market: Region-wise Outlook

The global kids’ sports injury treatmentmarket is expected to register a healthy CAGR during the forecast period. Depending on geographic region, global kids’ sports injury treatment market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa.

North America held largest share in the global market of kids’ sports injury treatment market followed by Europe, Japan and APAC owing to increase in the number of accidents while playing and developed healthcare infrastructure. The developing nations in APAC, MEA hold huge potential for growth in the global kids’ sports injury treatment market, due to the awareness and concern in the parents in regards to their children.

Kids Sports Injury Treatment Market: Key Players

Some of the key participating global players in kids’ sports injury treatment markets are Stop Sports Injuries, Arthrex, Inc., Smith and Nephew plc. Stryker Corporation, Zimmer Biomet Holdings Inc.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

Any Questions About Report, Ask Us @ https://www.futuremarketinsights.com/askus/rep-gb-1214

The report covers exhaustive analysis on:

• Market Segments
• Market Dynamics
• Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Technology
• Value Chain

Regional analysis includes

• North America (U.S., Canada)
• Latin America (Mexico, Brazil, Rest of Latin America)
• Western Europe (Germany, Italy, U.K, Spain, France, Rest of Western Europe)
• Eastern Europe (Poland, Russia)
• Asia Pacific (China, India, ASEAN, Australia & New Zealand)
• Japan
• Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Kids Sports Injury Treatment Market: Segmentation

Global kids sport injury treatmentmarket is classified on the basis of injury types and geography.